💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
TTK Healthcare Limited is an India-based company providing consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Animal Welfare segment offers products for veterinary…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A middling, stagnant business, fairly priced — but flagged on governance.
TTK Healthcare is scored on the pharma / healthcare framework. It keeps a slim 7.1% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT -0.32×) — worth a closer look. Free cash flow is worth about 2.4% of its market value.
Over the last 3 years revenue compounded at 6%/yr and profit at -53%/yr. Book value has grown 5%/yr. Return on equity is a weak 5.4%. In the latest quarter profit grew 948% versus the prior quarter.
At 20× earnings, the stock sits at the 45th percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price asks for only ~-12%/yr growth over a decade — undemanding expectations. The forensic screen raises 2 red flags: Only ₹-0.06 of cash per ₹1 profit over 4 years — earnings not converting to cash; 87% of pre-tax profit is other income, not operations.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 4.66 | — | — |
| P/B | 0.96 | 4.11 | better |
| EV/EBITDA | 0.77 | — | — |
| ROE | 5.39 | — | — |
| ROCE | 7.18 | 6.87 | better |
| ROA | 16.75 | — | — |
| Quick Ratio | 5.38 | 4.8 | better |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| 3M India | 58.2 | 16.6 | 27.2% |
| NAVA | 15.4 | 1.7 | 9.0% |
| DCM Shriram | 10.1 | 1.7 | 16.3% |
Revenue has grown every year across all 4 financial years shown. 6% CAGR — growing but slowly.
Revenue is outpacing profit (6% vs -53%) — costs are rising faster than the top line.
Operating margins have been stable around 9% — no major structural shift. The gap between operating and net margin is widening — interest or tax costs are rising.
ROE at 6% — modest; the capital isn't working hard. Low variance across years — a predictable business that earns steadily on its equity base.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. -53% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
4 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue fell 8% QoQ — could be seasonality or a genuine slowdown. Run-rate stepping up — recent quarters average 14% above earlier ones.
Profit jumped 948% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (5% → 88%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold 74.6% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.